Home/ Stocks/ ALVO

Alvotech Ordinary Shares

ALVO XNAS

$4.86 +0.31 (+6.81%) ▲ 15-min delayed

Open

$4.57

High

$4.93

Low

$4.57

Volume

1.02M

Market Cap

$1.73B

About Alvotech Ordinary Shares

Alvotech is a biopharmaceutical company focused solely on the development and manufacture of biosimilar medicines for patients globally. Its purpose is to improve the health and quality of life of patients around the world by improving access to treatments for various diseases. The company's commercialized products incldue AVT02, AVT03, AVT04, AVT05, and AVT06. Its pipeline contains eight biosimilar candidates aimed at treating autoimmune disorders, eye disorders, osteoporosis, and cancer. Geographically, the company generates the majority of revenue from Europe, and the rest from the USA and the rest of the world.

Employees: 1.5K Website →

Related Market News

No specific coverage for ALVO yet. Check out our latest market news or earnings calendar.

Get ALVO Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Alvotech Ordinary Shares.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.